Zobrazeno 1 - 10
of 71
pro vyhledávání: '"Christopher W. Rowe"'
Autor:
Winy Widjaja, Christopher W. Rowe, Christopher Oldmeadow, Daron Cope, Elizabeth A. Fradgley, Christine Paul, Christine J. O'Neill
Publikováno v:
Endocrinology, Diabetes & Metabolism, Vol 6, Iss 2, Pp n/a-n/a (2023)
Abstract Introduction De‐escalated treatment of hemithyroidectomy without radioactive iodine (RAI) is now accepted for patients with low‐risk, well‐differentiated thyroid cancer (WDTC). The benefit of long‐term follow‐up care remains contro
Externí odkaz:
https://doaj.org/article/6904cfa52a2a47ebbdfe92dbebfff9bf
Publikováno v:
Endocrinology, Diabetes & Metabolism Case Reports, Vol 1, Iss 1, Pp 1-6 (2021)
We report concurrent metastatic prostatic adenocarcinoma (PC) and functioning androgen-secreting adrenocortical carcinoma (ACC) in a 77-year-old man. The failure to achieve adequate biochemical castration via androgen deprivation therapy (ADT) as tre
Externí odkaz:
https://doaj.org/article/1e5470eba16943d7a03e03a1102b771b
Publikováno v:
PLoS Computational Biology, Vol 18, Iss 2, p e1009912 (2022)
Accurate quantification of nerves in cancer specimens is important to understand cancer behaviour. Typically, nerves are manually detected and counted in digitised images of thin tissue sections from excised tumours using immunohistochemistry. Howeve
Externí odkaz:
https://doaj.org/article/d27e67fd5de44a8894ac893641dd6d04
Autor:
Sam Faulkner, Nathan Griffin, Christopher W. Rowe, Phillip Jobling, Janine M. Lombard, Sonia M. Oliveira, Marjorie M. Walker, Hubert Hondermarck
Publikováno v:
FASEB BioAdvances, Vol 2, Iss 7, Pp 398-408 (2020)
Abstract Nerve growth factor (NGF) and its receptors are increasingly implicated in cancer progression, but their expression in cervical cancer is unclear. The objective of this study was to define the protein expression of NGF, its precursor (proNGF
Externí odkaz:
https://doaj.org/article/c993e07b2b364f0ea4cb27aaf9d18bbb
Autor:
Christopher W. Rowe, Sam Faulkner, Jonathan W. Paul, Jorge M. Tolosa, Craig Gedye, Cino Bendinelli, Katie Wynne, Shaun McGrath, John Attia, Roger Smith, Hubert Hondermarck
Publikováno v:
BMC Endocrine Disorders, Vol 19, Iss 1, Pp 1-8 (2019)
Abstract Background Nerves and neurotrophic growth factors are emerging promoters of cancer growth. The precursor for Nerve Growth Factor (proNGF) is overexpressed in thyroid cancer, but its potential role as a clinical biomarker has not been reporte
Externí odkaz:
https://doaj.org/article/472217499a334f7eb9d616eb0fd394ef
Publikováno v:
Clinical Thyroidology. 35:120-122
Autor:
Mark E. Fenton, Sarah A. Wade, Bibi N. Pirrili, Zsolt J. Balogh, Christopher W. Rowe, Cino Bendinelli
Publikováno v:
Journal of Clinical Medicine, Vol 10, Iss 18, p 4150 (2021)
Multidisciplinary team (MDT) meetings are the mainstay of the decision-making process for patients presenting with complex clinical problems such as papillary thyroid carcinoma (PTC). Adherence to guidelines by MDTs has been extensively investigated;
Externí odkaz:
https://doaj.org/article/3c94f834e1fc4170897f44aa4dcf106b
Autor:
Christopher W. Rowe
Publikováno v:
Clinical Thyroidology. 35:24-26
Autor:
Nicholas D. A. Blefari, Christopher W. Rowe, Elvina Wiadji, David Lambkin, Rosemary Carroll, Elizabeth A. Fradgley, Christine J. O’Neill
Publikováno v:
World Journal of Surgery. 46:2423-2432
Background Thyroid cancer diagnoses are increasing and treatment can lead to significant morbidity. Long-term health-related quality of life (HRQoL) in thyroid cancer is understudied and lacks reference populations. This study compares long-term HRQo
Publikováno v:
Endocrinology, Diabetes & Metabolism Case Reports, Vol 1, Iss 1, Pp 1-5 (2016)
Metastatic thyroid cancer is an uncommon condition to be present at the time of pregnancy, but presents a challenging paradigm of care. Clinicians must balance the competing interests of long-term maternal health, best achieved by iatrogenic hyperthy
Externí odkaz:
https://doaj.org/article/f64c4c9305d247c7a9526005bd97a0f1